Solid Biosciences Inc. SLDB
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 17.47% | -0.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.13% | 16.00% | |||
| Operating Income | -0.13% | -16.00% | |||
| Income Before Tax | 3.42% | -13.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.42% | -13.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.42% | -13.96% | |||
| EBIT | -0.13% | -16.00% | |||
| EBITDA | -0.14% | -16.30% | |||
| EPS Basic | 26.19% | 1.69% | |||
| Normalized Basic EPS | 26.17% | 1.70% | |||
| EPS Diluted | 26.19% | 1.69% | |||
| Normalized Diluted EPS | 26.17% | 1.70% | |||
| Average Basic Shares Outstanding | 30.85% | 15.92% | |||
| Average Diluted Shares Outstanding | 30.85% | 15.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||